Imidazoline receptor ligands:cardiovascular applications

Bibliography

• BOUSQUET P: Recent advances in imidazoline receptor research. Exp. Opine. Invest. Drugs (1995) 4(5) :431–442.
   Google Scholar
• ••A thorough review of imidazolines and their specific receptors.
   Google Scholar
• MOLDERINGS GJ: Imidazoline receptors: basic knowledge, recent advances and future prospects for therapy and diagnostic. Drugs Future (1997) 22 (7) 757–772.
   Google Scholar
• ERNSGERGER P, FRIEDMAN JE, KOLETSKY RJ: The 11-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease. J. Hypertens. (1997) 15\(Suppl. 1) :S9–S23.
   Google Scholar
• BOUSQUET P: Imidazoline receptors. Neurochem. mt. (1997) 30:3–7.
   PubMed Web of Science ®Google Scholar
• WILLENS HJ, CHAKKO S, SIMMONS Jet al.: Cost-effectiveness in clinical cardiology. Part 1: Coronary artery disease and congestive heart failure. Chest (1996) 109(5) :1359–1369.
   PubMed Web of Science ®Google Scholar
• MACKAIGUE JP, HARRON DWG: The effects of rilmenidine on tests of the autonomic function in humans. Clin. Pharmacol. Ther. (1992) 52:511–517.
   PubMed Web of Science ®Google Scholar
• HARRON DWG: Antihypertensive drugs and baroreflex sensitivity: effect of rilmenidine. Am. J. Med. (1989) 87(Suppl. 3C):575–625.
   Google Scholar
• THE CARDIAC ARRHYTHMIA SUPPRESSION TRIAL (CAST) INVESTIGATORS: Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. New Engl. J. Med. (1989) 21:406–412.
   Google Scholar
• YOUNG JB: Clinical trials with implications regarding heart failure therapy. Curr. Opine. Cardiol. (1997) 12:407–417.
   PubMed Web of Science ®Google Scholar
• PACKER M, BRISTOW MR, COHN JN, et al.: FOR THE US CARVEDILOL HEART FAILURE STUDY GROUP: The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. New Engl. J. Med. (1996) 334:1349–1355.
   PubMed Web of Science ®Google Scholar
• MANOLIS AJ, OLYMPIOS C, SIFAKI M, et al.: Combined sympathetic suppression and angiotensin-converting enzyme inhibition in congestive heart failure. Hypertension (1997) 29 (Part 2) :525–530.
   Web of Science ®Google Scholar
• ERNSBERGER PR, WESTBROOKS KL, CHRISTEN MO, et al.: A second generation of centrally acting antihypertensive agents act on putative 11-imidazoline receptors. In: The 11-Imidazoline Receptor Agonist Moxonidine. Schafer SG, Christen MO, Ernsberger PR (Eds,). Raven Health Care Communications, New York (1992) 1–19.
   Google Scholar
• BOUSQUET P, FELDMAN J, SCHWARTZ J: Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines. J. Pharmacol. Exp. Ther. (1984) 230:232–236.
   PubMed Web of Science ®Google Scholar
• ••The first suggestion of the existence of imidazoline-specific receptors.
   Google Scholar
• BRICCA G, DONTENWILL M, MOLINES A, et al.: Evidence for the existence of a homogenous population of imidazoline receptors in the human brainstem. Eur. J. Pharmacol. (1988) 150:401–402.
   PubMed Web of Science ®Google Scholar
• ••The first evidence of the existence of imidazoline binding sites in the human brain
   Google Scholar
• SEPAROVIC D, KESTER M, ERNSBERGER P: Coupling of I,-imidazoline receptors to diacylglyceride accumulation in PC12 rat pheochromocytoma cells. Mol. Pharmacol. (1996) 49:668–675.
   PubMed Web of Science ®Google Scholar
• ••An attempt to identify the process whereby imidazoline receptors are coupled.
   Google Scholar
• REGUNATHAN S, REIS DJ: Imidazoline receptors and their endogenous ligands. Ann. Rev. Pharmacol. Toxicol. (1996) 36:511–544.
   PubMed Web of Science ®Google Scholar
• PARINI A, MOUDANOS CG, PIZZINAT N, et al.: The elusive family of imidazoline binding sites. Trends Pharmacol. Sci. (1996) 17:13–16.
   PubMed Web of Science ®Google Scholar
• MACKAIGUE JP, HARRON DW: The effects of rilmenidine on tests of autonomic function in humans. Clin. Pharmacol. Ther. (1992) 52(5):511–517.
   PubMed Web of Science ®Google Scholar
• BARRON H, LESH MD: Autonomic nervous system and sudden cardiac death. J. Am. Coll. Cardiol. (1996) 27:1053–1060.
   PubMed Web of Science ®Google Scholar
• CHEN SA, LIU RH, TING TH, et al.: Termination of digitalis-induced ventricular tachycardias by clonidine involves central alpha 2-adrenoceptors in cats. Br. J. Pharmacol. (1991) 103:1114–1118.
   PubMed Web of Science ®Google Scholar
• ROEGEL JC, YANNOULIS N, DEJONG Wet al.: Inhibition of centrally-induced ventricular arrhythmias by rilmenidine and idazoxan in rabbits. Naunyn-Schmiedeberg's Arch. Pharmacol. (1996) 354:598–605.
   Google Scholar
• ••A report of an additional beneficial effect of imidazoline-like drugs.
   Google Scholar
• MEST HJ, THOMSEN P, RAAP A: Antiarrhythmic effect of the selective I,-imidazoline receptor modulator moxonidine on ouabain-induced cardiac arrhythmia in guinea pigs. Ann. NY Acad. Sci. (1995) 763:620–633.
   PubMedGoogle Scholar
• LEPRAN I, PAPP JP: Effect of moxonidine on arrhythmias induced by coronary artery occlusion and reperfusion. J. Cardiovasc. Pharmacol. (1994) 24\(Suppl. 1):S9–S15.
   PubMed Web of Science ®Google Scholar
• ESLER M: Sympathetic neurohormonal modulation in cardiovascular disease. Symposium on Heart Failure. Cologne, Germany (1997).
   Google Scholar
• COHN JN, LEVINE TB, OLIVARI MT, et al.: Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. New Engl. J. Med. (1984) 311:819–823.
   PubMed Web of Science ®Google Scholar
• GILES TD, ITELD BJ, MAUTNER RK, et al.: Short-term effects of intravenous clonidine in congestive heart failure. Clin. Pharmacol. Ther. (1981) 30:724–728.
   PubMed Web of Science ®Google Scholar
• HERMILLER JB, MAGORIEN RD, LEITHE ME, et al.: Clonidine in congestive heart failure: a vasodilator with negative inotropic effects. Am. J. Cardiol. (1983) 51:791–795.
   PubMed Web of Science ®Google Scholar
• Schafer SG, Christen MO, Ernsberger PR (Eds.), Raven Health Care Communications, New York (1992) :59–68.
   Google Scholar
• FILLASTRE JP: Effects of rilmenidine on the central nervous system and kidney. Arch. Mal. Coeur Vaiss. (1989) 82 (Spec. 5) :19–23.
   Google Scholar